2025 annual financial data
SELLAS Life Sciences Group 2025 Operating cash flow
Direct answer
Operating cash flow was -28,389,000 USD.
Operating income was -28,274,000 USD and net income was -26,863,000 USD.
Operating cash flow was -28,389,000 USD.
Get free SELLAS Life Sciences Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -28,274,000 USD
- Net income
- -26,863,000 USD
- Operating cash flow
- -28,389,000 USD